<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00725335</url>
  </required_header>
  <id_info>
    <org_study_id>SWHB001</org_study_id>
    <secondary_id>ISRCTN01960869</secondary_id>
    <nct_id>NCT00725335</nct_id>
  </id_info>
  <brief_title>Effect of I/R Injuries by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Hepatectomy</brief_title>
  <official_title>The Effect of Ischemia/Reperfusion Injuries Elicited by Pringle Manoeuvre on the Prognosis of HCC Patients After Curative Excision:A Multicenter Prospective Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southwest Hospital, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Chinese PLA General Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Fudan University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>First Affiliated Hospital, Sun Yat-Sen University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Southwest Hospital, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a multi-centre prospective randomized controlled trial to explore the influence of
      ischemia-reperfusion injuries elicited by pringle manoeuvre during radical excision on the
      prognosis of Hepatocellular Carcinoma (HCC) patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Until now there are two popular procedures during the radical excision of primary liver
      cancer in our country.One is to give a pringle manoeuvre to control the operative blood
      loss,the other is using a combination of CUSA and Tissue-link to control the bleeding while
      without liver ischemia.According to the recent experimental studies in rats,we know that the
      ischemia and reperfusion injury may contribute to the metastasis of the tumor.In order to
      test the actual contribution of ischemia on human,we conduct this prospective clinical trial
      to compare the two popular procedures' effect on the prognosis of liver cancer patients
      undergoing radical excision.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 2008</start_date>
  <completion_date type="Actual">November 2012</completion_date>
  <primary_completion_date type="Actual">June 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Disease free survival</measure>
    <time_frame>1,3,5-year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>overall survival,morbidity,postoperative mortality;blood loss,Liver function test,etc</measure>
    <time_frame>baseline~2 weeks, 5-year overall survival</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">498</enrollment>
  <condition>Hepatocellular Carcinoma</condition>
  <arm_group>
    <arm_group_label>group A,non-pringle group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intervention of curative resection of HCC Without pringle manoeuvre in this arm</description>
  </arm_group>
  <arm_group>
    <arm_group_label>pringle group(B)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>when the curative resection of HCC performed, the pringle manoeuvre will be routinely applied.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>curative resection without Pringle</intervention_name>
    <description>Radical excision of liver cancer without the procedure of pringle manoeuvre</description>
    <arm_group_label>group A,non-pringle group</arm_group_label>
    <other_name>Experimental group</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>curative resection with Pringle manoeuvre</intervention_name>
    <description>curative resection liver cancer under pringle manoeuvre</description>
    <arm_group_label>pringle group(B)</arm_group_label>
    <other_name>control group</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis of resectable primary liver cancer

          -  The liver function showed:Child-Pugh A，ICG-R15 ＜ 20%

          -  HbsAg (+)

          -  tumor nodes in the liver were singular or multiple and could be radical excision

          -  No preoperative anti-cancer therapy

          -  Written informed consent from the patient or legal guardian prior to entering the
             study

        Exclusion Criteria:

          -  Pregnancy patients

          -  With extrahepatic tumor or lymphnode metastasis

          -  Tumor invasion or thrombosis in portal vein,hepatic vein or inferior vena cava

          -  Positive marginal
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dong Jiahong, Ph D</last_name>
    <role>Study Director</role>
    <affiliation>Institue of hepatobiliary surgery,Chinese PLA General Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institute of hepatobiliary surgery,southwest hospital</name>
      <address>
        <city>Chongqing</city>
        <state>Chongqing</state>
        <zip>400038</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pubmed/22862951</url>
    <description>Protocol</description>
  </link>
  <verification_date>November 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>July 24, 2008</study_first_submitted>
  <study_first_submitted_qc>July 29, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 30, 2008</study_first_posted>
  <last_update_submitted>November 23, 2012</last_update_submitted>
  <last_update_submitted_qc>November 23, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">November 27, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Southwest Hospital, China</investigator_affiliation>
    <investigator_full_name>feng xiaobin</investigator_full_name>
    <investigator_title>Dr Feng xiaobin</investigator_title>
  </responsible_party>
  <keyword>ischemia</keyword>
  <keyword>liver cancer</keyword>
  <keyword>radical excision</keyword>
  <keyword>prognosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma, Hepatocellular</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

